Tavapadon will enter a competitive but commercially attractive market after a likely regulatory submission following post-hoc data.

Buntanetap showed dose-dependent and statistically significant improvements in cognition in the overall enrolled PD population. Parkinson’s patients with substantial cognitive decline exhibited a very ...

Tavapadon significantly improves motor function and activities of daily living in adults with early Parkinson disease compared with placebo.

Harrison et al. have attempted to validate Part II of the Unified Parkinson's Disease Rating Scale (UPDRS II) as a medication-independent measure of disease progression. The authors collected ...

In this double-blind trial, we examined the possibility that rasagiline has disease-modifying effects in Parkinson's disease. A total of 1176 subjects with untreated Parkinson's disease were randomly ...